BIOME TECHNOLOGIES PLC

AGM Information • Mar 13, 2025

National Storage Mechanism | Additional information

RNS Number : 5966A

Biome Technologies PLC

13 March 2025

13 March 2025

Biome Technologies plc

("Biome", the "Company" or the "Group")

Result of General Meeting and update on Cancellation

Biome Technologies plc, a leading bioplastics and radio frequency technology business, announces that at the General Meeting held earlier today, all resolutions put to Shareholders were duly passed.

The votes cast in respect of each resolution are as follows:

No.	Resolution	For*	%	Against	%	Withheld**
1	conditional upon the passing of Resolutions 2 and 3, to approve the Cancellation of the admission of the Ordinary Shares to trading on AIM	42,729,008	99.5	214,641	0.5	51,763
2	conditional upon the passing of Resolutions 1 and 3 and the Cancellation becoming effective, to approve the adoption of the New Articles	42,729,704	99.5	213,945	0.5	51,763
3	conditional upon the passing of Resolutions 1 and 2 and the Cancellation becoming effective, to approve the re-registration of the Company as a private limited company	42,729,704	99.5	213,945	0.5	51,763

* Includes those votes giving the Chairman discretion.

**A vote withheld is not a vote in law and is therefore not counted towards the proportion of votes "in favour" or "against" the resolutions.

As a result of the passing of the Resolutions, trading in the Company's Ordinary Shares on AIM will be cancelled at 07.00 a.m. on 21 March 2025. Shareholders are therefore reminded that the last day of dealings in the Company's Ordinary Shares on AIM will be 20 March 2025.

In accordance with the passing of the Resolutions, and subject to the Cancellation becoming effective, the Company will re-register as a private company limited by shares and adopt the new articles of association with effect from such re-registration.

Further details of the Cancellation, including the full text of the Resolutions, can be found in the circular which was published and sent to shareholders on 20 January 2025 and is available on the Company's website at  https://biometechnologiesplc.com/ .

Matched Bargain Facility

The Company is making arrangements for a Matched Bargain Facility to assist Shareholders to trade in the Ordinary Shares to be put in place from the date of the Cancellation. The Matched Bargain Facility is to be provided by JP Jenkins. JP Jenkins is an appointed representative of Prosper Capital LLP, which is authorised and regulated by the FCA.

It is intended that the Matched Bargain Facility will operate for a minimum of six months after the Cancellation. The Directors' current intention is that it will continue beyond that time, but Shareholders should note there remains a risk that the Matched Bargain Facility may not remain in place for an extended period of time and therefore inhibit the ability to trade the Ordinary Shares. The Company would expect to update its website (see above) before withdrawal of the Matched Bargain Facility.

Further details on the Matched Bargain Facility can be found in the circular sent to shareholders on 20 January 2025 and referred to above.

There can be no guarantee as to the level of the liquidity or marketability of the Ordinary Shares under the Matched Bargain Facility, or the level of difficultly for Shareholders seeking to realise their investment under the Matched Bargain Facility , or that the Matched Bargain Facility will remain in place for an extended period of time.  If Shareholders wish to buy or sell Ordinary Shares on AIM, they must do so prior to the Cancellation becoming effective.

Capitalised terms used in this announcement shall have the meanings given to such terms in the announcement issued by the Company dated 21 February 2025 unless otherwise defined herein.

-Ends-

For further information please contact:
Biome Technologies plc Donna Simpson-Strange, Company Secretary
www.biometechnologiesplc.com	Tel: +44 (0) 2380 867 100
Allenby Capital
David Hart/Alex Brearley/Lauren Wright (Nominated Adviser) Kelly Gardiner/Tony Quirke (Sales and Corporate Broking)
www.allenbycapital.com	Tel: +44 (0) 20 3328 5656

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ROMLXLFFEXLLBBB